How much did the US spend on Covid relief?
Table of Contents
How much did the US spend on Covid relief?
In early 2020, the U.S. Congress appropriated funds in response to the COVID-19 pandemic….How is total COVID-19 spending categorized?
| Agency | Department of the Treasury |
|---|---|
| Total Budgetary Resources | $1,536,321,405,090 |
| Total Obligations | $1,366,619,389,555 |
| Total Outlays | $1,365,733,946,658 |
How much money went to stimulus checks?
The total cost of the payments is estimated to be around $411 billion. The latest report from the IRS said that as of 12 May the agency had sent out around 165 million payment since 12 March 2021 to the tune of $388 billion.
A pair of Harvard economists estimates that the coronavirus pandemic will cost the nation at least $16 trillion if it ends by next fall — timing they describe as “optimistic” — and say that a number that large justifies interventions such as a coordinated nationwide program of testing and contact tracing that would …
How much did the US spend on Covid vaccine?
Most recently the Congressional Budget Office estimated that the Biomedical Research and Development Authority (BARDA) alone has spent $19.3 billion on COVID-19 vaccine development.
How much money is in the US Treasury 2020?
As of September 30, 2020: More than three-fourths of the federal government’s total assets ($6.0 trillion) consist of: 1) $1.9 trillion in cash and monetary assets, 2) $1.6 trillion in net loans receivable (primarily student loans), and 3) $1.1 trillion in net PP&E.
Is Canadian economy in debt?
Over the course of COVID-19, Canada’s deficit has grown faster than any other developed country, with the debt forecast to hit $1.6 trillion this year. “Government debt is not like household debt,” said Alex Hemingway, an economist at the Canadian Centre for Policy Alternatives.
What is Canada’s 2020 debt?
Federal interest-bearing debt at March 31, 2020 was $1.026 trillion.
How much money has the US government spent on Covid vaccines?
Most recently the Congressional Budget Office estimated that the Biomedical Research and Development Authority (BARDA) alone has spent $19.3 billion on COVID-19 vaccine development. In addition, Lisa Cornish projected $39.5 billion in US spending.